Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.66B |
| 2 |
Amazon
AMZN
|
+$421M |
| 3 |
Citigroup
C
|
+$386M |
| 4 |
Wells Fargo
WFC
|
+$288M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.18B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.45B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.45B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$503M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.99% |
| 2 | Technology | 1.99% |
| 3 | Consumer Discretionary | 1.08% |
| 4 | Financials | 1% |
| 5 | Communication Services | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
CALL
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $4.54M | ﹤0.01% |
150,300
+129,800
| +633% | +$3.94M |
|
3152
CALL
Ascendis Pharma A/S
ASND
$16.3B
| $4.54M | ﹤0.01% |
29,400
-86,600
| -75% | -$12.4M |
|
|
XLRN
3153
CALL
DELISTED
Acceleron Pharma
XLRN
| $4.54M | ﹤0.01% |
40,300
+7,800
| +24% | +$776K |
|
3154
BioCryst Pharmaceuticals
BCRX
$2.51B
| $4.53M | ﹤0.01% |
1,317,463
-102,524
| -7% | -$439K |
|
3155
Fox Factory Holding Corp
FOXF
$864M
| $4.52M | ﹤0.01% |
60,856
+48,192
| +381% | +$4.34M |
|
3156
CALL
LivePerson
LPSN
$34.8M
| $4.52M | ﹤0.01% |
5,800
+933
| +19% | +$700K |
|
3157
PUT
AllianceBernstein
AB
$3.43B
| $4.52M | ﹤0.01% |
167,200
-19,600
| -10% | -$548K |
|
3158
PUT
Transocean
RIG
$6.48B
| $4.52M | ﹤0.01% |
5,599,700
-1,524,500
| -21% | -$2.49M |
|
|
HRC
3159
PUT
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $4.52M | ﹤0.01% |
54,100
+17,900
| +49% | +$1.75M |
|
3160
Invesco S&P MidCap Low Volatility ETF
XMLV
$739M
| $4.52M | ﹤0.01% |
108,408
+26,671
| +33% | +$1.14M |
|
|
MYOV
3161
DELISTED
Myovant Sciences Ltd.
MYOV
| $4.51M | ﹤0.01% |
321,165
-14,824
| -4% | -$276K |
|
|
BMCH
3162
CALL
DELISTED
BMC Stock Holdings, Inc
BMCH
| $4.51M | ﹤0.01% |
105,300
+26,600
| +34% | +$876K |
|
3163
Cintas
CTAS
$81.7B
| $4.51M | ﹤0.01% |
54,168
-31,920
| -37% | -$2.46M |
|
|
PFPT
3164
CALL
DELISTED
Proofpoint, Inc.
PFPT
| $4.51M | ﹤0.01% |
42,700
-26,900
| -39% | -$3M |
|
3165
CALL
Green Plains
GPRE
$1.03B
| $4.51M | ﹤0.01% |
291,100
-95,800
| -25% | -$1.31M |
|
3166
PUT
Elanco Animal Health
ELAN
$12B
| $4.5M | ﹤0.01% |
161,300
-228,100
| -59% | -$5.78M |
|
3167
PUT
Zions Bancorporation
ZION
$9.89B
| $4.5M | ﹤0.01% |
154,000
-64,800
| -30% | -$2.09M |
|
|
NSLR
3168
PUT
Neostellar Capital Corp
NSLR
$270M
| $4.5M | ﹤0.01% |
494,142
+419,092
| +558% | +$4.39M |
|
3169
PUT
Trex
TREX
$4.66B
| $4.5M | ﹤0.01% |
62,800
-78,000
| -55% | -$5.4M |
|
3170
Aon
AON
$75.4B
| $4.49M | ﹤0.01% |
21,776
-10,922
| -33% | -$2.18M |
|
3171
CALL
CMS Energy
CMS
$21.4B
| $4.49M | ﹤0.01% |
73,100
+39,300
| +116% | +$2.41M |
|
3172
CALL
ProShares UltraShort QQQ
QID
$216M
| $4.49M | ﹤0.01% |
23,745
-7,870
| -25% | -$1.63M |
|
3173
CALL
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.6B
| $4.49M | ﹤0.01% |
24,900
+12,700
| +104% | +$2.24M |
|
|
ZUO
3174
DELISTED
Zuora, Inc.
ZUO
| $4.47M | ﹤0.01% |
431,988
+176,696
| +69% | +$2.05M |
|
3175
Zillow
ZG
$8.23B
| $4.47M | ﹤0.01% |
43,980
+38,498
| +702% | +$3M |
|
Similar funds
Jeff Yass's Q3 2020 Portfolio in Review
As of Q3 2020, Jeff Yass held 11,604 positions worth $522B, up 26% from $415B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jeff Yass's Q3 2020 filing shows 1,567 new, 4,405 increased, 4,403 reduced and 1,138 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,104,687 shares worth $284M. The largest sale was Invesco QQQ Trust, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,104,687 shares worth $284M.
- Jeff Yass added most to Apple in Q3 2020, an estimated $2.66B increase.
- Jeff Yass's biggest Q3 2020 reduction was Invesco QQQ Trust, cutting an estimated $3.18B.
- Jeff Yass fully exited Vanguard Short-Term Corporate Bond ETF in Q3 2020, selling an estimated $34.1M.
- Jeff Yass's ten largest holdings make up 34% of its $522B portfolio in Q3 2020.
- Jeff Yass opened 1,567 new positions and closed 1,138 in Q3 2020.
- Jeff Yass's portfolio value rose 26% quarter-over-quarter to $522B.
Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.